Shortage pharmaceuticals
Ended Awarded Last action
- Contract number
- 0012
- Awardee
-
TDS Med, Inc. UEI L8RFE2B8JCK4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $100,000
Award facts
- Contract value 100% obligated
- $100,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm-fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency to TDS Med, Inc., a small disadvantaged business, for the provision of shortage pharmaceuticals. The contract has a ceiling value of $100,000.00 and a period of performance through September 30, 2016. TDS Med, Inc. is a pharmaceutical company that specializes in emergency drug supply solutions, including blood products, inhalations, injectables, and other relevant pharmaceutical products. This contract supports the Defense Health Agency's requirements for shortage pharmaceuticals. Task orders are issued under this BPA to fulfill these needs. The contract does not have a set-aside designation.
Quick answers
Who was awarded contract 0012?
0012 was awarded to TDS Med, Inc. by Defense Health Agency (Department of Defense) on December 23, 2015.
How much is contract 0012 worth?
The government has obligated $100,000 on 0012.
Is contract 0012 an order under another contract?
Yes. 0012 is a BPA call under HT001414A0004, a blanket purchase agreement.
Was contract 0012 competed?
The extent of competition for 0012 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award